
11 - 50 employees
🏥 Healthcare
💼 Consulting
📦 Logistics
💰 $80M Post-IPO Equity - vTv Therapeutics on 2025-09
Healthcare • Consulting • Logistics
vTv Therapeutics is a late-stage biopharmaceutical company developing oral, small-molecule drug candidates to treat diabetes and other chronic diseases. Its lead clinical program is cadisegliatin, a liver-selective glucokinase activator currently in Phase 3 as a potential first-in-class oral adjunctive therapy to insulin for people with type 1 diabetes. vTv focuses on improving glycemic control and reducing hypoglycemia risk through novel oral therapies and maintains active investor relations and clinical development programs.
📡 We watch vTv Therapeutics's careers page
Several times a day
how often we check
2
roles posted in the last 30 days
Selected: 🆕 Date Added.
🔥 0 minutes ago
Regulatory Affairs leader guiding clinical-stage biopharma vTv Therapeutics’ oral small-molecule drug programs. Developing global regulatory strategies, submissions, and health-authority interactions through commercialization.
🇺🇸 United States – Remote
💰 $80M Post-IPO Equity - vTv Therapeutics on 2025-09
⏰ Full Time
🟠 Senior
🚔 Compliance
👻 Ghost score 15%
🔥 0 minutes ago
Associate Director, FP&A guiding budgets, forecasts and capital allocation for vTv Therapeutics’ Phase 3 diabetes drug programs. Partnering with clinical, R&D, accounting and leadership teams.
🇺🇸 United States – Remote
💵 $165k - $195k / year
💰 $80M Post-IPO Equity - vTv Therapeutics on 2025-09
⏰ Full Time
🟠 Senior
💸 Financial Planning and Analysis (FP&A)
👻 Ghost score 0%